Want to join the conversation?
Consumer credit reporting agency $EFX reported 1Q16 net income attributable to company of $102.1MM or $0.85 per diluted share, up 15.6% versus $88.3MM or $0.73 per diluted share in 1Q15, helped by higher operating revenue. Operating revenue rose 12% to $728.3MM in the quarter.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.